Literature DB >> 20726921

Squamous cell carcinoma arising from long-standing perianal fistula.

K Chandramohan1, Arun Peter Mathew, Madhu Muralee, K R Anila, K Ramachandran, Iqbal Ahamed.   

Abstract

Perianal fistula is a very common problem in general population. Ninety percent of perianal fistulae arise from infected anal glands, and they often give rise to perianal abscesses. Very rarely perianal fistulae and abscesses undergo malignant transformation and give rise to carcinomas, mainly adenocarcinomas. We are reporting a case of squamous cell carcinoma arising from long-standing perianal fistula and how we managed it surgically.
© 2010 The Authors. Journal Compilation © 2010 Blackwell Publishing Ltd and Medicalhelplines.com Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20726921      PMCID: PMC7951239          DOI: 10.1111/j.1742-481X.2010.00724.x

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  20 in total

Review 1.  Radical causes of cancer.

Authors:  S Perwez Hussain; Lorne J Hofseth; Curtis C Harris
Journal:  Nat Rev Cancer       Date:  2003-04       Impact factor: 60.716

2.  The internal anal sphincter and the anorectal abscess.

Authors:  S EISENHAMMER
Journal:  Surg Gynecol Obstet       Date:  1956-10

3.  Anal cancer incidence: genital warts, anal fissure or fistula, hemorrhoids, and smoking.

Authors:  E A Holly; A S Whittemore; D A Aston; D K Ahn; B J Nickoloff; J J Kristiansen
Journal:  J Natl Cancer Inst       Date:  1989-11-15       Impact factor: 13.506

4.  An assessment of the incidence of fistula-in-ano in four countries of the European Union.

Authors:  Carlo Zanotti; Carmen Martinez-Puente; Isabel Pascual; María Pascual; Dolores Herreros; Damián García-Olmo
Journal:  Int J Colorectal Dis       Date:  2007-06-07       Impact factor: 2.571

5.  Carcinoma in fistula-in-ano.

Authors:  J M MILLER; R J LIPIN
Journal:  Postgrad Med       Date:  1950-02       Impact factor: 3.840

6.  Elevated anal squamous cell carcinoma risk associated with benign inflammatory anal lesions.

Authors:  C Nordenvall; O Nyrén; W Ye
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

Review 7.  Connection between inflammation and carcinogenesis in gastrointestinal tract: focus on TGF-beta signaling.

Authors:  Suntaek Hong; Ho-Jae Lee; Seong Jin Kim; Ki-Baik Hahm
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

Review 8.  Chronic inflammation and cancer.

Authors:  Emily Shacter; Sigmund A Weitzman
Journal:  Oncology (Williston Park)       Date:  2002-02       Impact factor: 2.990

9.  Squamous cell carcinoma arising from recurrent anal fistula.

Authors:  Tomoko Seya; Noritake Tanaka; Seiichi Shinji; Kimiyoshi Yokoi; Tatsuo Oguro; Yoshiharu Oaki; Toshiyuki Ishiwata; Zenya Naito; Takashi Tajiri
Journal:  J Nippon Med Sch       Date:  2007-08       Impact factor: 0.920

10.  The role of endoscopic ultrasound in the evaluation of rectal cancer.

Authors:  Ali A Siddiqui; Yomi Fayiga; Sergio Huerta
Journal:  Int Semin Surg Oncol       Date:  2006-10-18
View more
  3 in total

1.  Giant squamous cell carcinoma as a complication of a chronic enterocutaneous fistula: complex parietal reconstruction.

Authors:  Lionel Rebibo; Jean-Baptiste Deguines; Flavien Prevot; David Pérignon; Raphaël Sinna; Pierre Verhaeghe; Jean-Marc Regimbeau
Journal:  Int Wound J       Date:  2012-09-13       Impact factor: 3.315

2.  Non-mucinous adenocarcinomas and squamous cell carcinomas of the anal region masquerading as abscess or fistula: a retrospective analysis and systematic review of literature.

Authors:  Aysun Tekbaş; Henning Mothes; Utz Settmacher; Silke Schuele
Journal:  J Cancer Res Clin Oncol       Date:  2021-08-02       Impact factor: 4.322

3.  Anal Neoplasia in Inflammatory Bowel Disease Is Associated With HPV and Perianal Disease.

Authors:  Joannie Ruel; Huaibin Mabel Ko; Giulia Roda; Ninad Patil; David Zhang; Bindia Jharap; Noam Harpaz; Jean-Frédéric Colombel
Journal:  Clin Transl Gastroenterol       Date:  2016-03-03       Impact factor: 4.488

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.